Three "Zhejiang Young Craftsmen" Out of the Peak"
Release time:
2022-03-01
News from our newspaper Peak Pharmaceutical has produced three "Zhejiang Young Craftsmen"! A few days ago, the "Zhejiang Young Craftsmen" training project released a list of candidates for 2021 . Three employees of Jianfeng Pharmaceutical Company, Wang Liqin, Yang Shiqiang and Zhu Guoping, were successfully selected.
"Zhejiang Young Craftsmen" is a training project jointly organized and implemented by the Zhejiang Provincial Department of Human Resources and Social Security and the Provincial Committee of the Communist Youth League. It is also a part of the "New Era Zhejiang Craftsmen" training support project set up by the Provincial Party Committee and Provincial Government for high-skilled talents. component. It is understood that Zhejiang craftsmen in the new era are divided into 9 levels: Zhejiang great craftsmen, Zhejiang outstanding craftsmen, Zhejiang craftsmen and Zhejiang young craftsmen 4 , which are respectively given different amounts of special financial support for training. Among them, the training period of Zhejiang young craftsmen is one year, and the provincial finance and the local finance each support 1 yuan, which is mainly used for technological innovation, skill training, master and apprenticeship, team building, team building, and cooperation and exchange, etc. Zhejiang Young Craftsman 2021 was the first batch of selection, and a total of 25 people were selected in Jinhua Development Zone, where Peak Pharmaceutical is located.
According to the spirit of relevant documents, Zhejiang young craftsmen are based on the strategic positioning of focusing on building a global advanced manufacturing base, focusing on the province's economic development leading industries, key industries and front-line industrial workers with high technical skills. Selected; candidates should consciously support the party's line, principles and policies, abide by the law, love their jobs, and have good professional ethics and superb skills, and in Zhejiang full-time work 1 years or more, in principle, should have senior work and above vocational qualifications (vocational skill level), under the age of 35 , master skilled skills, full of development potential, or in vocational skills won the title of prefecture-level technical expert in the competition, or in the development of technological innovation, technological transformation, overcome technical difficulties to make contributions to create benefits for enterprises and society. The recommended candidates focus on manufacturing enterprises, using the difference method, bottom-up, layer-by-layer selection, merit-based recommendation method for selection.
Among the three Zhejiang young craftsmen selected by Jianfeng Pharmaceutical, Yang Siqiang's professional job is electrician. He joined Jianfeng Pharmaceutical in 2011 and won the title of "Excellent Employee" of Jianfeng Pharmaceutical three times. In 2020 , he won the honor of "Technical Expert" in the Craftsman Cup Skills Competition of Jinxi Development Zone. Wang Liqin's professional job is a drug inspector, she joined Jianfeng Pharmaceutical as QA in 2010 and is now the deputy director of the comprehensive preparation workshop. She was awarded the title of "Outstanding Scientific and Technological Worker" by Jianfeng Pharmaceutical. She was elected as a representative of Wucheng District People's Congress and published 2 papers in national journals. Zhu Guoping's job is maintenance electrician, and he joined Jianfeng Pharmaceutical in 2016 , 2019 won the title of "100 front-line outstanding technical employees" in the development zone, won the honor of "innovation expert" in the group company in 2021 , and is currently an automation technician in the engineering support department. The company will combine their respective characteristics and professional skills background, combine theory and practice, tailor-made training plan to help them grow rapidly. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page